Company / FCF Margin
Kura Oncology, Inc. FCF Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-104.8%
FY2025
5-year range
-104.8% / 248.4%
FY2024-FY2025
Trend
-142.2%
vs FY2024
Sector context
#89 of 134
Health Care
What the data says
At -104.8%, Kura Oncology, Inc.'s fcf margin ranks #89 of 134 in the Health Care sector.
Based on SEC 10-K filings.
-104.8% in FY2025.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#89 of 134 in Health CareTop 66% of 134This company -104.8% Sector average -637.8%
▼
+83.6% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 142.2% year-over-year.
- Currently 533.0pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -104.8% | -142.2% |
| FY2024 | 248.4% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026